Best Peptide Protocols
    Hormonal / Growth HormoneSingle

    Tesamorelin 5mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for Tesamorelin (5 mg Vial).

    Strength & Form:5 mg Vial10 mg Vial
    Tesamorelin (5 mg Vial) peptide vial

    Tesamorelin (5 mg Vial)

    5 mg Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Single
    Category
    Hormonal / Growth Hormone
    Vial Strength
    5 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete Tesamorelin 5mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is Tesamorelin 5mg?

    Tesamorelin 5mg Vial Overview

    Tesamorelin is a synthetic GHRH analog consisting of the full 44-amino acid human GHRH sequence with a trans-3-hexenoic acid modification for enhanced stability. It is FDA-approved for reducing excess abdominal fat (lipodystrophy) in HIV-infected patients. Research shows tesamorelin significantly reduces visceral adipose tissue, improves trunk-to-limb fat ratio, and increases IGF-1 without impairing glucose metabolism.

    Tesamorelin 5mg Quick Reference

    Tesamorelin 5mg Vial Specifications

    Peptide
    Tesamorelin (5 mg Vial) (NNMT inhibitor)
    Vial Content
    5 mg total peptide
    Category
    Hormonal / Growth Hormone
    Administration Method
    Subcutaneous injection
    Common Use Case
    Visceral fat reduction and physiologic GH optimization

    Tesamorelin 5mg Compared With Other Formats

    Details that distinguish this 5 mg format include:

    • FDA-approved for lipodystrophy—highest regulatory confidence
    • Full-length GHRH analog for most physiologic GH release
    • Proven visceral fat reduction in clinical trials

    How Does Tesamorelin Work?

    Tesamorelin Mechanism of Action

    Tesamorelin is the full 44-amino acid human GHRH with a trans-3-hexenoic acid group for enhanced stability. It provides the most physiologic GH stimulation among available GHRH analogs. FDA-approved for HIV-associated lipodystrophy, it reduces visceral adipose tissue by 15–18% without affecting subcutaneous fat or glucose metabolism.

    What Are the Potential Benefits of Tesamorelin?

    Tesamorelin Research Findings and Observed Outcomes

    Findings and reported areas of study for Tesamorelin (5 mg Vial) include:

    • Significant visceral fat reduction
    • Physiologic GH release pattern
    • Improved trunk-to-limb fat ratio
    • No glucose metabolism impairment

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute Tesamorelin 5mg?

    Tesamorelin 5mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31 gauge)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    Tesamorelin 5mg Administration and Research Protocol

    Tesamorelin Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyOnce daily
    TimingBefore bedtime or morning fasted

    Abdominal injection is standard. Rotate sites.

    Tesamorelin 5mg Dosage Guide

    Tesamorelin Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range1 mg per day
    Standard Range2 mg per day (FDA-approved dose)
    Upper Range2 mg per day

    Tesamorelin 5mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    1 mg0.25 mL25 units
    2 mg0.50 mL50 units

    This dosing table is unique to the 5 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a Tesamorelin 5mg Vial Last?

    Tesamorelin 5mg Duration by Research Dose

    At common research doses, one 5 mg vial of Tesamorelin typically supports:

    1 mg per day~5 days at 1 mg
    2 mg per day (FDA-approved dose)~2.5 days at 2 mg
    2 mg per dayN/A

    Clinical protocols ran 26–52 weeks continuously.

    How to Reconstitute Tesamorelin 5mg

    Tesamorelin 5mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the Tesamorelin (5 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    1.25 mL
    Final Concentration
    4 mg/mL

    Tesamorelin 5mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    Tesamorelin Stacks and Research Combinations

    Tesamorelin and Compatible Research Pairings

    In research settings, Tesamorelin (5 mg Vial) is sometimes paired with peptides such as:

    Factors That May Affect Tesamorelin Research Outcomes

    Supporting Factors for Tesamorelin Research

    Factors recorded alongside this protocol include:

    • Balanced nutrition
    • Regular exercise targeting visceral fat
    • Quality sleep
    • Stress management

    These factors can affect how research observations are interpreted.

    Tesamorelin Side Effects and Safety Considerations

    Tesamorelin 5mg Tolerability Notes

    FDA-approved with well-characterized safety profile.

    Some individuals report:

    • Injection site reactions
    • Joint pain
    • Peripheral edema
    • Paresthesia

    How to Store Tesamorelin Before and After Reconstitution

    Tesamorelin 5mg Storage Requirements

    Unreconstituted
    Refrigerate or freeze
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Up to 4 weeks

    Who Should Avoid Tesamorelin?

    This peptide is generally not recommended for:

    • Pregnant or breastfeeding individuals
    • Active cancer
    • Pituitary surgery or disease
    • Anyone advised otherwise by a healthcare professional

    Tesamorelin 5mg FAQs

    Is Tesamorelin FDA-approved?

    Yes, under the brand name Egrifta® for reducing excess abdominal fat in HIV-infected patients with lipodystrophy.

    Where to Buy Tesamorelin 5mg for Research

    Tesamorelin 5mg Purchasing and Research Supply Notes

    Before ordering Tesamorelin (5 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for Tesamorelin (5 mg Vial):

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Hormonal / Growth Hormone Peptides

    CJC-1295 No DAC (5 mg Vial) productCJC-1295 No DAC (5 mg Vial)CJC-1295 DAC (5 mg Vial) productCJC-1295 DAC (5 mg Vial)GHRP-2 (5 mg Vial) productGHRP-2 (5 mg Vial)GHRP-6 (5 mg Vial) productGHRP-6 (5 mg Vial)Hexarelin (5 mg Vial) productHexarelin (5 mg Vial)IGF-1 LR3 (1 mg Vial) productIGF-1 LR3 (1 mg Vial)